Therefore, deficit in CREB signaling may be implicated in AD pathology through the detrimental effects of Aβ (Scott Bitner 2012; Bartolotti et al., 2016; Yin et al., 2016). This evidence concerns the gene CREB1 and Alzheimer disease.